The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
Part II: Subject File, 1902-2012 (continued)
BOX II:98 Antihypertensives, 1969-1972, 1978-1986, undated
BOX II:98 Antimalarial Program and antimalarial drugs See Containers II:91-II:92, Essentials of Pharmacology, Chapter 29
BOX II:98 Antimetabolites/anticancer, 1954-1985, 1991, undated See also Container II:173, Methotrexate
BOX II:98 Apgar, Virginia, 1960, 1968, 1984-1985, 2000, undated
BOX II:98 Aprindine See Container II:139, Eli Lilly and Co. Task Group
BOX II:98 Archer, John D. See Container II:196, same heading
BOX II:98 Aronow, Wilbert S., investigation
BOX II:98 1979-1982
BOX II:99 1983-1984, 1996-1997
(2 folders)
BOX II:99 Artificial sweeteners
BOX II:99 Aspartame/NutraSweet See Container II:145, same heading
BOX II:99 Cyclamates, 1965-1971, undated
BOX II:99 Saccharin, 1977
BOX II:99 Aspirin See Container II:191, Salicylates
BOX II:99 Asteroids, 1972-1985, 1994-1998
BOX II:99 Ayerst Laboratories, New York, N.Y. See Container II:187, Practolol
BOX II:99 Barbituates, 1972, 1980-1982
BOX II:99 Baycol, 2001
BOX II:99 Behavioral teratology, 1938, 1961-1986, 1992, undated
(4 folders)
BOX II:100 Bendectin, 1962-1999, undated See also Containers II:170-II:171, Maternal-Child Problems Task Force
(5 folders)
BOX II:100 Benoxaprofen (Oraflex), 1983-1988 See also Container II:139, Eli Lilly and Co. Task Group
BOX II:100 Beta-blockers See Container II:98, Antihypertensives
BOX II:100 Bioavailability, 1971, 1984-1991
BOX II:100 Biopharmaceutics, 1981, 1989
BOX II:100 Bioresearch Monitoring Program (BIMO), U.S. Food and Drug Administration
BOX II:100 Automatic Data Processing budget, 1983-1985
BOX II:100 Clinical Investigations Data File System, 1969, 1979-198-1983, 1999, undated
(3 folders)
BOX II:101 Clinical investigators form and clinical facilities file system, 1969-1975, 1999, undated
BOX II:101 General
BOX II:101 1971-1979
(7 folders)
BOX II:101 1980
(1 folder)
BOX II:102 (1 folder)
BOX II:102 1981-1982
(5 folders)
BOX II:102 1983
(1 folder)
BOX II:103 (1 folder)
BOX II:103 1984-1999, undated
(4 folders)
BOX II:103 Information Systems User Committee/BIMO Systems Task Group
BOX II:103 Chronology, 1979-1980
BOX II:103 General
BOX II:103 1977-1978
(2 folders)
BOX II:103 1979
(1 folder)
BOX II:104 (1 folder)
BOX II:104 1980-1982
(6 folders)
BOX II:105 1983, 1999
(4 folders)
BOX II:105 Presentation to BIMO Steering Committee, 1978, 1999
BOX II:105 Key events in National Center for Drugs and Biologics, circa 1981
BOX II:105 Meetings
BOX II:105 BIMO program managers
BOX II:105 1996
(5 folders)
BOX II:106 1997
(10 folders)
BOX II:106 Compliance Coordinating Committee, 1996
BOX II:106 Project Management Systems, implementation sessions
BOX II:106 1975-1980
(3 folders)
BOX II:107 1981-1983
(2 folders)
BOX II:107 Reports
BOX II:107 Annual, Fiscal Year 1980-Fiscal Year 1984
(5 folders)
BOX II:107 Monthly
BOX II:107 1984
BOX II:108 1985-1988
(6 folders)
BOX II:108 1989
BOX II:108 Jan.-Mar.
(2 folders)
BOX II:109 Apr.-Nov.
(6 folders)
BOX II:110 Dec.
BOX II:110 1990
(4 folders)
BOX II:110 1991
BOX II:110 Jan.-July
(2 folders)
BOX II:111 Aug.-Dec.
(2 folders)
BOX II:111 1992
(5 folders)
BOX II:112 1993
(4 folders)
BOX II:112 1994
BOX II:112 Jan.-Apr.
(2 folders)
BOX II:113 May-Dec.
(3 folders)
BOX II:113 1995
BOX II:113 Jan.-Aug.
(3 folders)
BOX II:114 Sept.-Dec.
BOX II:114 1996
(5 folders)
BOX II:114 Transfer of classification No Action Indicated for BIMO inspection reports to field offices, 1979
BOX II:114 Work plans, 1987-1990
BOX II:115 Birth defects/reviews, 1976, 1986-1990
BOX II:115 Birth surveys, 1963-1999, undated
(4 folders)
BOX II:115 Breast milk, drugs in, 1947-1993, 2001, undated
(2 folders)
BOX II:116 Bromocryptine, 1977-1985
BOX II:116 Bureau of Drugs, U.S. Food and Drug Administration
BOX II:116 Clinical Investigator Stratified Surveillance Strategy, 1976-1980, undated
BOX II:116 Deputy director, 1979-1982
(2 folders)
BOX II:116 Caffeine, 1966, 1978-1982, undated
BOX II:116 Carcinogenesis/teratology, 1963-1983, undated
BOX II:116 Carrisyn/Carrington Laboratories, Dallas, Tex., 1986-1996
(2 folders)
BOX II:116 Celebrex/Vioxx, 1999-2002
BOX II:117 Center for Drug Evaluation and Research, U.S. Food and Drug Administration
BOX II:117 General, 1997-2000, undated
Next Page »

Contents List